ADIM
MCK icon

Alpha DNA Investment Management’s McKesson MCK Stock Holding History

Alpha DNA Investment Management’s Portfolio MCK Stock Details MCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,166
Closed -$736K – 180
2022
Q3 		$736K Sell
2,166
-754
-26% -$262K 0.61% 52
2022
Q2 		$951K Buy
+2,920
New +$934K 0.81% 75
2021
Q1 		– Sell
-76
Closed -$13K – 746
2020
Q4 		$13K Buy
+76
New +$12.7K 0.01% 284

Other funds holding MCK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Alpha DNA Investment Management's MCK Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of McKesson (MCK) in Q4 2022, closing a stake of 2,166 shares — an estimated $736K sold.

Alpha DNA Investment Management first reported a position in MCK in Q4 2020 and held it in 3 quarters. The position peaked at $951K in Q2 2022. 1,288 funds tracked by Wall St. Rank hold MCK as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining McKesson position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,166 McKesson shares in Q4 2022, an estimated $736K.
  • Alpha DNA Investment Management first reported a position in McKesson in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's McKesson position peaked at $951K in Q2 2022.
  • 1,288 funds tracked by Wall St. Rank held McKesson as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.